000 | 00955 a2200265 4500 | ||
---|---|---|---|
005 | 20250518083700.0 | ||
264 | 0 | _c20200727 | |
008 | 202007s 0 0 eng d | ||
022 | _a1532-8171 | ||
024 | 7 |
_a10.1016/j.ajem.2020.01.041 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrown, Caitlin S | |
245 | 0 | 0 |
_aThe authors reply: Still much to learn about andexxa alfa in the ED. _h[electronic resource] |
260 |
_bThe American journal of emergency medicine _c04 2020 |
||
300 |
_a827-828 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aFactor Xa |
650 | 0 | 4 | _aFactor Xa Inhibitors |
650 | 0 | 4 | _aRecombinant Proteins |
700 | 1 | _aScott, Rachael A | |
700 | 1 | _aSridharan, Meera | |
700 | 1 | _aRabinstein, Alejandro A | |
773 | 0 |
_tThe American journal of emergency medicine _gvol. 38 _gno. 4 _gp. 827-828 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajem.2020.01.041 _zAvailable from publisher's website |
999 |
_c30601629 _d30601629 |